M032 + PEMBROLIZUMAB

2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

M032 + PEMBROLIZUMAB
Treatment and conditionWhere it standsTrials
M032 + PEMBROLIZUMAB for glioblastomaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
M032 + PEMBROLIZUMAB for gliosarcomaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1